ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (557 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/S0166-6851(02)00133-0    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2002 Published by Elsevier Science B.V. All rights reserved.

Leishmania RAB7: characterisation of terminal endocytic stages in an intracellular parasite

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Paul W. Denny, Sharon Lewis1, Jane E. Tempero, David Goulding, Alasdair C. Ivens2, Mark C. Field and Deborah F. SmithCorresponding Author Contact Information, E-mail The Corresponding Author

Wellcome Trust Laboratories for Molecular Parasitology and Centre for Molecular Microbiology and Infection, Department of Biological Sciences, Imperial College of Science, Technology and Medicine, London SW7 2AZ, UK


Accepted 20 June 2002. 
Available online 11 July 2002.

Abstract

Leishmania species are intracellular parasites that inhabit a parasitophorous vacuole (PV) within host macrophages and engage with the host endo-membrane network to avoid clearance from the cell. Intracellular Leishmania amastigotes exhibit a high degree of proteolytic/lysosomal activity that may assist degradation of MHC class II molecules and subsequent interruption of antigen presentation. As an aid to further analysis of the endosomal/lysosomal events that could facilitate this process, we have characterised a Leishmania homologue of the late endosomal marker, Rab7, thought to be involved in the terminal steps of endocytosis and lysosomal delivery. The Leishmania major Rab7 (LmRAB7) protein is expressed throughout the life-cycle, shows 73 and 64% identity to Trypanosoma cruzi and Trypanosoma brucei Rab7s (TcRAB7 and TbRAB7), respectively, and includes a kinetoplastid-specific insertion. The recombinant protein binds GTP and polyclonal antibodies raised against this antigen recognise structures in the region of the cell between the nucleus and kinetoplast. By immunoelectron microscopy of axenic amastigotes, Leishmania mexicana Rab7 (LmexRAB7) is found juxtaposed to and overlapping membrane structures labelled for the megasomal marker, cysteine proteinase B, confirming a late-endosomal/lysosomal localisation.

Author Keywords: Small GTPase; Lysosome; Endocytosis; Rab7

Abbreviations: conA, concanavalin A; DAPI, 4′,6-diamidino-2-phenylindole; DIC, differential interference contrast; EST, expressed sequence tag; FITC, fluorescein isothiocynanate; GAP, GTPase activating protein; GST, glutathione S transferase; HASPB, hydrophilic acylated surface protein B; MHC, major histocompatibility complex; MVT, multivesicular tubule; NMT, N-myristoyl transferase; PV, parasitophorous vacuole; TRITC, tetramethylrhodamine isothiocynanate

Article Outline

1. Introduction
2. Materials and methods
2.1. Parasites
2.2. Cloning of LmRAB7
2.3. Expression of LmRAB7
2.4. Immunofluorescent microscopy
2.5. Immuno-electron microscopy
3. Results and discussion
3.1. Identification of a Rab7 homologue in L. major
3.2. LmRAB7 is a GTP binding protein expressed throughout the Leishmania life cycle
3.3. LmRAB7 localises to the Leishmania late endosomal/lysosomal region
3.4. Conclusions
Acknowledgements
References





1 Present address: Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic. 3052, Australia.

2 Present address: The Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 ISA, UK.

Corresponding Author Contact Information Corresponding author. Tel.: +44-20-7594-5282; fax: +44-20-7594-5283; email: d.smith@ic.ac.uk


 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2009 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.